In-vivo bending area explosion impact explosive release energetic microsystem and implementation method thereof

Abstract

The invention discloses an explosion impact explosive release energetic microsystem in an in-vivo bending area and an implementation method of the explosion impact explosive release energetic microsystem. The in-vivo bending area explosion impact drug release energetic microsystem comprises an endoscope, a telescopic mechanism, an explosion drug release micromodule, a system shell and an in-vitro control module. When the endoscope observes that the endoscope reaches a focus designated area, a U-shaped electromagnetic coil in the telescopic mechanism is powered on, an iron core is attracted to enable a spring to extend, a movable sliding block is driven to slide, and an explosion drug release module is pushed out of a system shell through a drug release module release hole to be aligned with the focus area; explosive of the explosive release micromodule is detonated, detonation waves and high-pressure gas are formed to impact the explosive, and the explosive is accurately sprayed to the surface of the focus through an explosive release opening in the top end of the transparent explosive cover; the drug delivery system is applied to targeted therapy of in-vivo tubular structures such as gastrointestinal tracts and tracheas in human bodies, fixed-point release of drugs is achieved, meanwhile, the drugs are injected into and cover focus areas for targeted therapy, the treatment time is shortened, and the utilization rate of the drugs is increased.

Description

technical field [0001] The invention relates to the energy-containing microsystem technology for drug release, in particular to an energy-containing microsystem for explosive impact drug release in a bending area in the body and a realization method thereof. Background technique [0002] A large number of drugs need to be ingested by injection and oral administration. Due to the enzymatic degradation, the oral drug availability is greatly reduced. In addition to the pain caused by subcutaneous injection, the treatment time for some lesions in the body is greatly prolonged. Therefore, implantable mechanisms to release drugs in vivo for targeted therapy have attracted more and more attention. At present, targeted therapy in the human body is mainly aimed at tubular structures such as the gastrointestinal tract and trachea. However, complex and narrow areas in the body, such as the small intestine, large intestine, and stomach, often have curved and tortuous areas. Drugs canno...

AI Technical Summary

Problems solved by technology

At present, targeted therapy in the human body is mainly aimed at tubular structures such as the gastrointestinal tract and trachea. However, complex and narrow areas in the body, such as the small intestine, large intestine, and stomach, often have curved and tortuous areas. The drug cannot reach the lesion quickly, which increases the difficulty of treatment and prolongs the pain of the patient

Images